Research Article
Point-of-Care (POC) Urinary L-Type Fatty Acid-Binding Protein (u-LFABP) Use in Critically Ill, Very Preterm Neonates
Table 3
u-LFABP levels based on disease severity.
| | u-LFABP | value | Abnormal | Normal |
| PDA | 0–48 hours | | | 0.517 | Spontaneous | 4/5 (80.0) | 1/5 (20.0) | | PCT 1 cycle | 2/2 (100.0) | 0/2 (0.0) | | PCT >1 cycle | 4/4 (100.0) | 0/4 (0.0) | | 72 hours+ | | | 0.732 | Spontaneous | 3/4 (75.0) | 1/4 (25.0) | | PCT 1 cycle | 2/2 (100) | 0/2 (0.0) | | PCT >1 cycle | 3/4 (75.0) | 1/4 (25.0) | | 21 days+ | | | 0.011 | Spontaneous | 0/3 (0.0) | 3/3 (100.0) | | PCT 1 cycle | 1/1 (100.0) | 0/1 (0.0) | | PCT >1 cycle | 5/5 (100.0) | 0/5 (0.0) | |
| NEC | 0–48 hours | | | 1.000 | Grade 1 | 1/1 (100.0) | 0/1 (0.0) | | Grade 2 | 6/8 (75.0) | 2/8 (25.0) | | 72 hours+ | | | 1.000 | Grade 1 | 1/1 (100.0) | 0/1 (0.0) | | Grade 2 | 6/7 (85.7) | 1/7 (14.3) | | 21 days+ | | | 1.000 | Grade 1 | 1/1 (100.0) | 0/1 (0.0) | | Grade 2 | 3/5 (60.0) | 2/5 (40.0) | |
|
|
value <0.05. +Missing urine samples. n (%) is presented; fisher’s exact test. PDA: patent ductus arteriosus; NEC: necrotizing enterocolitis. |